← Back to all trials
Active Not Recruiting
NCT06243978
Effectiveness of a Digital Health Application for Primary Hypertension (Liebria)
Conditions: Hypertension
Sex: All
Ages: 18 Years – N/A
Healthy volunteers: No
Phase: NA
Enrollment: 328
Sponsor: Gaia AG
Location: GAIA AG Hamburg Free and Hanseatic City of Hamburg
Summary
This clinical trial with 328 patients with primary hypertension aims to investigate the effectiveness of the self-guided digital application liebria for patients with primary hypertension.
Eligibility Criteria
Inclusion Criteria:
* Age ≥ 18
* Presence of primary hypertension, confirmed by submission of a medical certificate or equivalent (e.g., informal letter signed by primary care physician); relevant ICD-10-GM diagnoses:
* I10.00 (Benign essential hypertension: Without indication of hypertensive crisis)
* I10.90 (Essential hypertension, unspecified: Without indication of hypertensive crisis)
* Unmedicated or with existing antihypertensive drug therapy (with stable dose in the past 6 weeks prior to study enrolment)
* Last reported office-based systolic blood pressure (SBP) ≥ 140 mmHg followed by home-based SBP ≥ 135 mmHg
* Consent to participate
Exclusion Criteria:
* Home-based SBP \> 180 mmHg
* \> Triple combination of antihypertensive medication
* History of secondary hypertension (e.g., thyroid disease, kidney disease)
* Pregnancy
Source: ClinicalTrials.gov (NCT06243978). StuddyBuddy aggregates publicly available trial information.